Healthcare — Major Healthcare Shifts: J&J's Groundbreaking Psoriasis Pill, FDA Leadership Change, and Legal Blocks to HHS Vaccine Policy

Healthcare · 2026-03-19

Today marks a confluence of significant regulatory and market developments that reshape the healthcare landscape. Johnson & Johnson's breakthrough with the first oral psoriasis treatment comparable to injectables signals a potential disruption in the multibillion-dollar autoimmune market. Meanwhile, the FDA faces a leadership vacuum in infectious diseases with Adam Sherwat's departure, just as a…